ATP6V1G1P1

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, ATP6V1G1P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ATP6V1G1P1’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where ATP6V1G1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP6V1G1P1 is over-expressed in tumor.

PRAD and BRCA are the cancer types where ATP6V1G1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP6V1G1P1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
PRADAllAll+0.205.0112view →
BRCAAllII,III,IV+0.014.0142view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ATP6V1G1P1–PRAD

Tumor-vs-normal expression box plot for ATP6V1G1P1 RNA in PRAD.

Open the PRAD breakdown →

Exploration